New Developments in Treating Genetic Disorders: The Global Market

Report Highlights

• The global market for products to treat genetic disorders was worth $12.8 billion in 2009 and is estimated to reach $17.3 billion by 2014, a compound annual growth rate (CAGR) of more than 6%.
  
• The gene mutation disorder segment is the largest in terms of sales and is considered to be a more successful area for development activity. This segment generated $11.3 billion in 2009 and is projected to increase at a compound annual growth rate (CAGR) of 6.5% to reach $15.6 billion in 2014.
  
• The chromosomal disorders segment was valued at $1.5 billion in 2009. By 2014, this market is expected to be worth $1.8 billion, a compound annual growth rate (CAGR) of 3.7%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES 

• Cystic fibrosis
• Fabry disease
• Gaucher’s disease
• Hemophilia
• Huntington’s disease
• Hunter syndrome
• Hurler syndrome
• Klinefelter syndrome
• Maroteaux–Lamy syndrome
• Phenylketonuria (PKU)
• Prader–Willi syndrome
• Pompe disease
• Turner’s syndrome

Each market segment discussion provides detailed information based on current product availability, uses of products, forecasts, and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.

• Examine BCC’s complete catalog of Market Research Reports and place direct orders
• Subscribe to any of BCC’s many industry newsletters
• Read announcements of recently published reports and newly launched newsletters
• Register for BCC’s well-known conferences
• Request additional information on any BCC product
• Take advantage of special offers